δ-catenin Inhibitors

The category of compounds termed δ-Catenin Inhibitors includes various chemicals that indirectly influence the activity of δ-catenin. These inhibitors primarily function by modulating signaling pathways related to cell adhesion, signaling, and cellular communication, rather than directly binding to or inhibiting δ-catenin. The primary mechanism through which these inhibitors exert their effects involves the modulation of the Wnt/β-catenin pathway, a crucial signaling pathway in cell development and adhesion, which is closely related to the function of δ-catenin. Compounds such as XAV-939, ICG-001, JW55, PKF115-584, and FH535 are known to inhibit the Wnt/β-catenin pathway, which can indirectly affect δ-catenin's role in cellular processes. By influencing this pathway, these compounds can potentially alter the interaction of δ-catenin with other cellular components, impacting its role in cell adhesion and signaling.

Other compounds, like Lithium Chloride and WAY-316606, also target signaling pathways that are indirectly connected to δ-catenin functions. These compounds may influence δ-catenin activity through their broader effects on cell signaling and communication. In addition, natural compounds such as Quercetin, EGCG, Curcumin, and Resveratrol, known for their broad spectrum of biological activities, can modulate various signaling pathways, including those related to cell adhesion and Wnt signaling. While their effects on δ-catenin are indirect, they could contribute to altered δ-catenin dynamics due to their wide-ranging impacts on cellular signaling networks.